3|0|Public
40|$|V, 106 p. Ill. SYNTHESIS 6 [...] 1. INTRODUCTION 6 [...] 1. 1. COMPLEXITY OF PATIENT COST SHARING FOR AMBULATORY PHYSICIAN-PATIENT CONTACTS 6 [...] 1. 2. SIMPLIFICATION WITHIN THE CONTOURS OF THE CURRENT HEALTH INSURANCE SYSTEM 7 [...] 2. A SUCCESSION OF AD HOC MEASURES SINCE 1963 8 [...] 2. 1. THE HEALTH INSURANCE ACT OF 9 AUGUST 1963 LAID THE FOUNDATIONS OF THE CURRENT SYSTEM 8 [...] 2. 2. BUDGET-DRIVEN REFORMS 8 [...] 2. 3. INCENTIVE-BASED REFORMS 9 [...] 3. POLICY OPTIONS TO SIMPLIFY THE CURRENT STRUCTURE OF CO-PAYMENTS AND COINSURANCE RATES FOR PHYSICIAN-PATIENT CONTACTS 9 [...] 3. 1. GLOBAL FINANCIAL IMPACT FOR RIZIV/INAMI AND FOR PATIENTS PER POLICY REFORM 11 [...] 3. 1. 1. GP {{consultations}} 12 [...] 3. 1. 2. GP visits 12 [...] 3. 1. 3. Specialist consultations 12 [...] 3. 2. FINANCIAL IMPACT FOR PATIENT SUBGROUPS OF ALTERNATIVE POLICY REFORMS 14 [...] 4. DISCUSSION AND CONCLUSION 14 [...] SCIENTIFIC REPORT 17 [...] 1. INTRODUCTION 17 [...] 1. 1. GENERAL BACKGROUND 17 [...] 1. 2. RESEARCH QUESTIONS AND SCOPE OF THE STUDY 18 [...] 1. 2. 1. Scope of {{the study}} 18 [...] 1. 2. 2. Research questions 19 [...] 1. 3. METHODS 20 [...] 1. 4. CONTENT OF THE REPORT 20 [...] 2. A HISTORICAL OVERVIEW OF THE STRUCTURE OF CO-PAYMENTS AND COINSURANCE RATES FOR GP AND SPECIALIST- PATIENT CONTACTS 20 [...] 2. 1. MAIN LEGISLATIVE REFORMS SINCE 1963 20 [...] 2. 1. 1. The Health Insurance Act of 1963 20 [...] 2. 1. 2. Changes in cost-sharing rules {{as a response to}} a new economic context 22 [...] 2. 1. 3. Changes in cost-sharing rules to steer patient demand 23 [...] 2. 2. DETERMINING FACTORS OF THE CURRENT STRUCTURE OF CO-PAYMENTS AND [...] COINSURANCE RATES 28 [...] 2. 2. 1. GP office consultations 28 [...] 2. 2. 2. GP home visits 30 [...] 2. 2. 3. Specialist consultations 37 [...] 3. PATHWAYS TO SIMPLIFY THE STRUCTURE OF CO-PAYMENTS AND COINSURANCE RATES FOR PHYSICIAN-PATIENT CONTACTS 40 [...] 3. 1. DESCRIPTION OF THE DATA 41 [...] 3. 2. MICROSIMULATION TECHNIQUE AS A TOOL FOR THE ANALYSIS OF POLICY MEASURES 41 [...] 3. 3. PRINCIPLES GOVERNING SIMPLIFYING REFORMS 42 [...] 3. 3. 1. General principles governing cost-sharing differentiation 42 [...] 3. 3. 2. General principles governing cost-sharing simplification 43 [...] 3. 3. 3. Limited financial impact and in line with current legal stipulations 43 [...] 3. 4. SIMULATION RESULTS: FINANCIAL IMPACT FOR RIZIV/INAMI AND FOR PATIENTS 43 [...] 3. 4. 1. Financial impact for patient subgroups of reforms for GP consultations 44 [...] 3. 4. 2. Financial impact for patient subgroups of reforms for GP visits 50 [...] 3. 4. 3. Financial impact for patient subgroups of reforms for specialist consultations 55 [...] 3. 4. 4. Global financial impact for RIZIV/INAMI and patients per policy reform 59 [...] APPENDICES 63 [...] APPENDIX 1. CONSTRUCTION OF THE FINAL DATASET 63 [...] APPENDIX 1. 1. SELECTION OF NOMENCLATURE CODES 63 [...] APPENDIX 1. 2. SETTING UP THE BASELINE SIMULATION 72 [...] APPENDIX 1. 3. ADAPTING THE SAMPLE TO THE EVOLUTION OF <b>PREFERENTIAL</b> <b>REIMBURSEMENT</b> [...] AND GMD/DMG BETWEEN 2009 AND 2011 74 [...] APPENDIX 1. 4. DEFINITION OF VARIABLES USED IN THE ANALYSIS 77 [...] APPENDIX 2. TECHNICAL DETAILS OF THE SIMULATIONS 81 [...] APPENDIX 2. 1. NUMBER OF PATIENTS AND AVERAGE NUMBER OF CONSULTATIONS AND VISITS PER PATIENT SUBGROUP 82 [...] APPENDIX 2. 2. TECHNICAL DOCUMENTATION SHEETS 88 [...] REFERENCES 10...|$|E
40|$|VI, 108 p. Ill. SYNTHÈSE 6 [...] 1. INTRODUCTION 6 [...] 1. 1. LA FAÇON DONT SONT RÉGLÉES LES CONTRIBUTIONS PERSONNELLES DES PATIENTS DANS LE CADRE DES CONTACTS MÉDECINS-PATIENTS AMBULATOIRES EST COMPLEXE 6 [...] 1. 2. SIMPLIFICATION DANS LES LIMITES DU SYSTÈME DASSURANCE MALADIE ACTUEL 7 [...] 2. UNE SUCCESSION DE MESURES AD HOC DEPUIS 1963 8 [...] 2. 1. LA LOI SUR LASSURANCE MALADIE DU 9 AOÛT 1963 CONSTITUE LA BASE DU SYSTÈME ACTUEL 8 [...] 2. 2. RÉFORMES BUDGÉTAIRES 8 [...] 2. 3. DES INCITANTS FINANCIERS DÉTERMINENT LE COMPORTEMENT 9 [...] 3. OPTIONS STRATÉGIQUES POUR SIMPLIFIER LA STRUCTURE ACTUELLE DES TICKETS MODÉRATEURS DANS LE CADRE DES CONTACTS MÉDECINS-PATIENTS 10 [...] 3. 1. IMPACT FINANCIER GLOBAL DE CHAQUE MESURE POUR LINAMI ET LES PATIENTS 13 [...] 3. 1. 1. Consultations des médecins généralistes 13 [...] 3. 1. 2. Visites à {{domicile}} des médecins généralistes 14 [...] 3. 1. 3. Consultations des spécialistes 14 [...] 3. 2. IMPACT FINANCIER DES RÉFORMES SUR CERTAINS GROUPES DE PATIENTS 14 [...] 4. DISCUSSION ET CONCLUSION 16 [...] 4. 1. ABSENCE DAPPROCHE COORDONNÉE 16 [...] 4. 2. UNE AUTRE EXPLICATION POSSIBLE DE LA COMPLEXITÉ 16 [...] 4. 3. TICKETS MODÉRATEURS EN MONTANT FIXE VERSUS EXPRIMÉS EN POURCENTAGE 16 [...] 4. 4. TRANSPARENCE 17 [...] SCIENTIFIC REPORT 19 [...] 1. INTRODUCTION 19 [...] 1. 1. GENERAL BACKGROUND 19 [...] 1. 2. RESEARCH QUESTIONS AND SCOPE OF THE STUDY 20 [...] 1. 2. 1. Scope of {{the study}} 20 [...] 1. 2. 2. Research questions 21 [...] 1. 3. METHODS 22 [...] 1. 4. CONTENT OF THE REPORT 22 [...] 2. A HISTORICAL OVERVIEW OF THE STRUCTURE OF CO-PAYMENTS AND COINSURANCE RATES FOR GP AND SPECIALIST- PATIENT CONTACTS 22 [...] 2. 1. MAIN LEGISLATIVE REFORMS SINCE 1963 22 [...] 2. 1. 1. The Health Insurance Act of 1963 22 [...] 2. 1. 2. Changes in cost-sharing rules {{as a response to}} a new economic context 24 [...] 2. 1. 3. Changes in cost-sharing rules to steer patient demand 25 [...] 2. 2. DETERMINING FACTORS OF THE CURRENT STRUCTURE OF CO-PAYMENTS AND COINSURANCE RATES 30 [...] 2. 2. 1. GP office consultations 30 [...] 2. 2. 2. GP home visits 32 [...] 2. 2. 3. Specialist consultations 39 [...] 3. PATHWAYS TO SIMPLIFY THE STRUCTURE OF CO-PAYMENTS AND COINSURANCE RATES FOR PHYSICIAN-PATIENT CONTACTS 42 [...] 3. 1. DESCRIPTION OF THE DATA 43 [...] 3. 2. MICROSIMULATION TECHNIQUE AS A TOOL FOR THE ANALYSIS OF POLICY MEASURES 43 [...] 3. 3. PRINCIPLES GOVERNING SIMPLIFYING REFORMS 44 [...] 3. 3. 1. General principles governing cost-sharing differentiation 44 [...] 3. 3. 2. General principles governing cost-sharing simplification 45 [...] 3. 3. 3. Limited financial impact and in line with current legal stipulations 45 [...] 3. 4. SIMULATION RESULTS: FINANCIAL IMPACT FOR RIZIV/INAMI AND FOR PATIENTS 45 [...] 3. 4. 1. Financial impact for patient subgroups of reforms for GP consultations 46 [...] 3. 4. 2. Financial impact for patient subgroups of reforms for GP visits 52 [...] 3. 4. 3. Financial impact for patient subgroups of reforms for specialist consultations 57 [...] 3. 4. 4. Global financial impact for RIZIV/INAMI and patients per policy reform 61 [...] APPENDICES 65 [...] APPENDIX 1. CONSTRUCTION OF THE FINAL DATASET 65 [...] APPENDIX 1. 1. SELECTION OF NOMENCLATURE CODES 65 [...] APPENDIX 1. 2. SETTING UP THE BASELINE SIMULATION 74 [...] APPENDIX 1. 3. ADAPTING THE SAMPLE TO THE EVOLUTION OF <b>PREFERENTIAL</b> <b>REIMBURSEMENT</b> AND GMD/DMG BETWEEN 2009 AND 2011 76 [...] APPENDIX 1. 4. DEFINITION OF VARIABLES USED IN THE ANALYSIS 79 [...] APPENDIX 2. TECHNICAL DETAILS OF THE SIMULATIONS 83 [...] APPENDIX 2. 1. NUMBER OF PATIENTS AND AVERAGE NUMBER OF CONSULTATIONS AND VISITS PER PATIENT SUBGROUP 84 [...] APPENDIX 2. 2. TECHNICAL DOCUMENTATION SHEETS 90 [...] REFERENCES 10...|$|E
40|$|V, 108 p. Ill. SYNTHESE 6 [...] 1. INLEIDING 6 [...] 1. 1. WIJZE WAAROP DE EIGEN BIJDRAGEN VAN PATIËNTEN IN DE AMBULANTE ARTSPATIËNTENCONTACTEN GEREGELD ZIJN, IS COMPLEX 6 [...] 1. 2. VEREENVOUDIGINGEN BINNEN DE GRENZEN VAN HET HUIDIGE ZIEKTEVERZEKERINGSSYSTEEM 7 [...] 2. EEN OPEENVOLGING VAN AD HOC MAATREGELEN SINDS 1963 8 [...] 2. 1. DE WET OP DE ZIEKTEVERZEKERING VAN 9 AUGUSTUS 1963 VORMT DE BASIS VAN HET HUIDIGE SYSTEEM 8 [...] 2. 2. BUDGETTAIR GEÏNSPIREERDE HERVORMINGEN 8 [...] 2. 3. FINANCIËLE PRIKKELS STUREN GEDRAG 9 [...] 3. BELEIDSOPTIES OM DE HUIDIGE REMGELDSTRUCTUUR BIJ ARTSPATIËNTENCONTACTEN TE VEREENVOUDIGEN 10 [...] 3. 1. GLOBALE FINANCIËLE IMPACT VAN ELKE MAATREGEL VOOR HET RIZIV EN DE PATIËNTEN 13 [...] 3. 1. 1. Raadplegingen van huisartsen 13 [...] 3. 1. 2. Huisbezoeken van huisartsen 13 [...] 3. 1. 3. Raadplegingen van specialisten 14 [...] 3. 2. FINANCIËLE IMPACT VAN HERVORMINGEN OP BEPAALDE GROEPEN VAN PATIËNTEN 14 [...] 4. DISCUSSIE EN BESLUIT 16 [...] 4. 1. EEN GECOÖRDINEERDE AANPAK ONTBREEKT 16 [...] 4. 2. EEN ANDERE MOGELIJKE VERKLARING VOOR DE COMPLEXITEIT 16 [...] 4. 3. VASTE VERSUS PROCENTUELE REMGELDEN 16 [...] 4. 4. TRANSPARANTIE 17 [...] SCIENTIFIC REPORT 19 [...] 1. INTRODUCTION 19 [...] 1. 1. GENERAL BACKGROUND 19 [...] 1. 2. RESEARCH QUESTIONS AND SCOPE OF THE STUDY 20 [...] 1. 2. 1. Scope of {{the study}} 20 [...] 1. 2. 2. Research {{questions}} 21 [...] 1. 3. METHODS 22 [...] 1. 4. CONTENT OF THE REPORT 22 [...] 2. A HISTORICAL OVERVIEW OF THE STRUCTURE OF CO-PAYMENTS AND COINSURANCE RATES FOR GP AND SPECIALIST- PATIENT CONTACTS 22 [...] 2. 1. MAIN LEGISLATIVE REFORMS SINCE 1963 22 [...] 2. 1. 1. The Health Insurance Act of 1963 22 [...] 2. 1. 2. Changes in cost-sharing rules {{as a response to}} a new economic context 24 [...] 2. 1. 3. Changes in cost-sharing rules to steer patient demand 25 [...] 2. 2. DETERMINING FACTORS OF THE CURRENT STRUCTURE OF CO-PAYMENTS AND COINSURANCE RATES 30 [...] 2. 2. 1. GP office consultations 30 [...] 2. 2. 2. GP home visits 32 [...] 2. 2. 3. Specialist consultations 39 [...] 3. PATHWAYS TO SIMPLIFY THE STRUCTURE OF CO-PAYMENTS AND COINSURANCE RATES FOR PHYSICIAN-PATIENT CONTACTS 42 [...] 3. 1. DESCRIPTION OF THE DATA 43 [...] 3. 2. MICROSIMULATION TECHNIQUE AS A TOOL FOR THE ANALYSIS OF POLICY MEASURES 43 [...] 3. 3. PRINCIPLES GOVERNING SIMPLIFYING REFORMS 44 [...] 3. 3. 1. General principles governing cost-sharing differentiation 44 [...] 3. 3. 2. General principles governing cost-sharing simplification 45 [...] 3. 3. 3. Limited financial impact and in line with current legal stipulations 45 [...] 3. 4. SIMULATION RESULTS: FINANCIAL IMPACT FOR RIZIV/INAMI AND FOR PATIENTS 45 [...] 3. 4. 1. Financial impact for patient subgroups of reforms for GP consultations 46 [...] 3. 4. 2. Financial impact for patient subgroups of reforms for GP visits 52 [...] 3. 4. 3. Financial impact for patient subgroups of reforms for specialist consultations 57 [...] 3. 4. 4. Global financial impact for RIZIV/INAMI and patients per policy reform 61 [...] APPENDICES 65 [...] APPENDIX 1. CONSTRUCTION OF THE FINAL DATASET 65 [...] APPENDIX 1. 1. SELECTION OF NOMENCLATURE CODES 65 [...] APPENDIX 1. 2. SETTING UP THE BASELINE SIMULATION 74 [...] APPENDIX 1. 3. ADAPTING THE SAMPLE TO THE EVOLUTION OF <b>PREFERENTIAL</b> <b>REIMBURSEMENT</b> AND GMD/DMG BETWEEN 2009 AND 2011 76 [...] APPENDIX 1. 4. DEFINITION OF VARIABLES USED IN THE ANALYSIS 79 [...] APPENDIX 2. TECHNICAL DETAILS OF THE SIMULATIONS 83 [...] APPENDIX 2. 1. NUMBER OF PATIENTS AND AVERAGE NUMBER OF CONSULTATIONS AND VISITS PER PATIENT SUBGROUP 84 [...] APPENDIX 2. 2. TECHNICAL DOCUMENTATION SHEETS 90 [...] REFERENCES 10...|$|E

